Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter

Slides:



Advertisements
Similar presentations
Volume 15, Issue 2, Pages (August 2001)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 18, Issue 5, Pages (May 2003)
Volume 26, Issue 3, Pages (March 2007)
Volume 13, Issue 5, Pages (November 2000)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 5, Issue 3, Pages (September 1996)
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 2, Pages (August 1999)
Volume 11, Issue 5, Pages (November 1999)
Volume 19, Issue 6, Pages (December 2003)
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Volume 18, Issue 5, Pages (May 2003)
Volume 131, Issue 1, Pages (October 2007)
Volume 9, Issue 4, Pages (October 1998)
Volume 10, Issue 5, Pages (November 2002)
Volume 29, Issue 6, Pages (December 2008)
Balthazar B Cazac, Jürgen Roes  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 1, Pages (July 2009)
Volume 13, Issue 3, Pages (September 2000)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 20, Issue 1, Pages (January 2004)
In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death  Kong-Peng Lam, Ralf Kühn, Klaus.
Impaired Th2 Subset Development in the Absence of CD4
CD22 is a negative regulator of B-cell receptor signalling
Volume 23, Issue 3, Pages (September 2005)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor–mediated p38α activation and impairs interferon-γ production by Ludmila Jirmanova,
Volume 13, Issue 4, Pages (October 2000)
A Point Mutation in the Constant Region of Ig Lambda1 Prevents Normal B Cell Development due to Defective BCR Signaling  Tianhe Sun, Marcus R Clark, Ursula.
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 5, Issue 3, Pages (September 1996)
Volume 25, Issue 5, Pages (November 2006)
Volume 25, Issue 6, Pages (December 2006)
Volume 28, Issue 5, Pages (May 2008)
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Altered Antigen Presentation in Mice Lacking H2-O
Volume 84, Issue 4, Pages (February 1996)
Volume 15, Issue 5, Pages (November 2001)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 9, Issue 5, Pages (November 1998)
Altered Antigen Presentation in Mice Lacking H2-O
Volume 29, Issue 1, Pages (July 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 15, Issue 2, Pages (August 2001)
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 31, Issue 2, Pages (August 2009)
Volume 10, Issue 4, Pages (April 1999)
Volume 16, Issue 4, Pages (April 2002)
Volume 32, Issue 1, Pages (January 2010)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 20, Issue 3, Pages (March 2012)
Volume 35, Issue 4, Pages (October 2011)
Volume 14, Issue 1, Pages (January 2001)
B Cell Development under the Condition of Allelic Inclusion
Volume 10, Issue 2, Pages (February 1999)
Volume 22, Issue 3, Pages (March 2005)
Volume 14, Issue 3, Pages (March 2001)
Volume 4, Issue 5, Pages (May 1996)
Volume 11, Issue 2, Pages (August 1999)
Presentation transcript:

Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter Markus Mohrs, Kanade Shinkai, Katja Mohrs, Richard M Locksley  Immunity  Volume 15, Issue 2, Pages 303-311 (August 2001) DOI: 10.1016/S1074-7613(01)00186-8

Figure 1 Targeting of the IRES-EGFP Reporter into the Mouse IL-4 Locus (A) Map of the mouse IL-4 locus, the reporter-targeting construct, and the mutated gene. A genomic 5 kb EcoRI fragment from the wild-type locus (top panel) was mutated by the introduction of a loxP-flanked (filled triangles) drug-selectable neomycin cassette (neo), followed by an internal ribosomal entry site (IRES) element, enhanced green fluorescent protein (EGFP), and a polyadenylation signal (pA) (middle panel). After successful targeting in PrmCre embryonic stem cells, the neo cassette was deleted by Cre-mediated recombination in the male germline of chimeric males, thereby creating the final arrangement depicted at the bottom of the panel. Numbered, filled boxes indicate exons. The following abbreviations are used: tk, thymidine kinase cassette; B, BamHI; E, EcoRI. (B) Southern blot analysis of DNA from tail biopsies from offspring of heterozygous breeding. DNA was digested with BamHI and hybridized with probe a (dark line, top panel, Figure 1A). A new BamHI site introduced by the targeting construct results in a 7 kb fragment in place of the 17 kb BamHI fragment in the wild-type locus. Genotypes are indicated as wild-type (+/+), heterozygous knockin (+/4get) and homozygous knockin (4get/4get) Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)

Figure 2 EGFP Expression of 4get T Cells In Vitro (A) FACS histograms of wild-type (gray fill), heterozygous 4get (thin line), and homozygous 4get (bold line) CD4+ T cells. Naive CD4+ EGFP− T cells were purified by cell sorting and cultured under Th2 conditions in the presence of antigen-presenting cells. After days indicated, EGFP expression was analyzed after gating on CD4+ cells. (B) As in (A), but naive CD8+ T cells were purified and primed instead of CD4+ T cells. (C) As in (A), but Stat6−/−/4get (dotted line) CD4+ T cells were compared to wild-type (gray fill) and homozygous 4get cells (bold line). (D) Purified, naive CD4+ EGFP− homozygous 4get T cells were labeled with the red fluor PKH26. Cells were cultured under Th1, neutral, or Th2 conditions in the presence of antigen-presenting cells and analyzed on day 4 after gating on CD4+ cells. Cells cultured for 4 days under Th2 conditions but without anti-TCR/CD28 stimulation (far-right panel) demonstrate that dilution of PKH26 intensity requires TCR stimulation Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)

Figure 3 Cytokine Secretion by 4get T Cells (A) Splenocytes from wild-type (+/+, open bars) and heterozygous (+/4get, hatched bars) or homozygous (4get/4get, dark bars) 4get mice were depleted of CD8+ cells by complement lysis and stimulated under Th1, neutral, or Th2 conditions for 5 days. Cells were washed and restimulated, and supernatants were collected after 48 hr and analyzed for IL-4 and IFN-γ by ELISA. Mean and positive standard deviations of triplicate cultures are shown. (B) Purified, naive CD4+ EGFP− T cells from wild-type, 4get, and 4get/Stat6−/− were cultured under Th2 conditions with antigen-presenting cells. After 5 days, cells were restimulated with plate-bound anti-CD3 mAb for 6 hr, and serial dilutions of viable cells were analyzed by ELISPOT. Mean and positive standard deviations of triplicate cultures are shown Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)

Figure 4 Spontaneous EGFP Expression in 4get Mice Infected with N. brasiliensis (A) Homozygous 4get mice were infected with N. brasiliensis. FACS analysis of lung, mesenteric lymph nodes (MLN), peripheral lymph nodes (PLN), and spleen (SPL) was performed after 10 days. Cells from the forward- and side-scatter lymphocyte gate were examined for CD4 and EGFP expression. Noninfected control mice were housed in the same facility as infected mice. Cells from 3 mice were pooled for each analysis. Numbers indicate percentages per quadrant. (B) As in (A), but the analysis was performed by gating on EGFP+ lung lymphocytes for the expression of DX5 and CD3 on indicated days after infection. R1 = DX5lo CD3lo cells, R2 = DX5+ CD3hi cells. (C) As in (A), but mice were analyzed on indicated days after infection for the percent of EGFP cells in designated tissues. Dark fill indicates CD4+ CD3lo DX5+ cells, hatched fill indicates CD4+ CD3hi DX5+ cells, gray fill indicates CD4+ CD3hi DX5− cells, and open fill indicates CD4− CD3− DX5− cells Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)

Figure 5 EGFP Expression in 4get/Stat6−/− Mice Infected with N. brasiliensis Homozygous 4get and 4get/Stat6−/− mice were infected with N. brasiliensis. FACS analysis of lung and mesenteric lymph nodes was performed on day 8 and day 11 after infection. Cells from the forward- and side-scatter lymphocyte gate were examined for EGFP and CD4 expression. Cells from three mice were pooled prior to analysis. Numbers indicate percentages per quadrant Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)

Figure 6 Adoptive Transfer of EGFP+ Effector T Cells into TCR Cα-Deficient Mice Homozygous 4get mice (depicted in black) were infected with N. brasiliensis. After 12 days, mesenteric lymph nodes (MLN) were analyzed for CD44 and EGFP expression in CD4+ T cells, and 7 × 105 purified EGFP+ CD4+ T cells were transferred intravenously into TCR Cα-deficient mice (depicted in white). Thirty days later, MLN of recipient mice (hatched) were analyzed for EGFP expression on gated CD4+ cells. Remaining recipient mice were infected with N. brasiliensis, and MLN cells were analyzed for CD44 and EGFP expression on gated CD4+ T cells 10 days later Immunity 2001 15, 303-311DOI: (10.1016/S1074-7613(01)00186-8)